Back

Integrating pre- and post-ablation B-type natriuretic peptide to identify high-risk population for long-term adverse events and arrhythmic recurrence in persistent atrial fibrillation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and heart failure: a deadly combination Mechanisms for Heart Failure and Cardiac Complications ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Shintaro Hashimoto

Yamaguchi University Graduate School of Medicine, Ube (Japan)

4 More presentations in this session

Presentation thumbnail
Prognostic implications of atrial fibrillation in young patients without overt heart disease - an early marker of future cardiomyopathy ?
Doctor P. Rasmussen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Tachycardiomyopathy is associated with metabolic changes that predict LVEF recovery - results from the EMPATHY study
Doctor D. Heinzmann (Tuebingen, DE)
Abstract Slides Video
Presentation thumbnail
ECG changes predict new-onset heart failure in patients with atrial fibrillation.
Doctor C. Binding (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Care and outcomes of atrial fibrillation in potentially vulnerable populations: A 20-year perspective using real-world data
Doctor N. Nouhravesh (Durham, US)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and heart failure: a deadly combination
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
NT-proBNP may be used as a risk factor of stroke after the elimination of atrial fibrillation by catheter ablation
thumbnail
Congress Presentation
Impact of continuous ECG monitoring after catheter ablation of persistent atrial fibrillation in patients with left ventricular systolic dysfunction - long term results from a single-centre registry
thumbnail
Congress Presentation
Clinical determinants of blood biomarkers of atrial cardiomyopathy: results from the ISOLATION AF ablation cohort study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources